SCHEMBL5267005

SCHEMBL5267005

O=C(O)NCC=Cc1ccc(F)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.48
GRIK1 P39086 1/20 0.47
GRIK2 Q13002 1/20 0.47
LMNA P02545 3/20 0.46
TP53 P04637 1/20 0.46
POLB P06746 2/20 0.46
KMT2A Q03164 2/20 0.46
MMP1 P03956 2/20 0.45
MMP2 P08253 2/20 0.45
MMP9 P14780 2/20 0.45
EGFR P00533 1/20 0.45
TNFRSF1A P19438 1/20 0.44
NFE2L2 Q16236 2/20 0.44
MAOB P27338 1/20 0.44
SMN1; SMN2 Q16637 4/20 0.43
GAA P10253 1/20 0.43
RECQL P46063 1/20 0.41
MEN1 O00255 1/20 0.41
HPGD P15428 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1582564 0.83 MAOB (0.61) LMNAKMT2AMMP1MMP2MMP9
SCHEMBL1694508 0.83 MAOB (0.61) LMNAKMT2AMMP1MMP2MMP9
SCHEMBL11551476 0.81 LMNA (0.47) HSD11B1GRIK1GRIK2LMNATP53
SCHEMBL9790517 0.79 RAB9A (0.54) LMNAPOLBKMT2AMMP1MMP2
SCHEMBL9790513 0.79 RAB9A (0.54) LMNAPOLBKMT2AMMP1MMP2
SCHEMBL1694974 0.77 MAPT (0.51) GRIK1GRIK2LMNAKMT2AMAOB
SCHEMBL1694975 0.77 MAPT (0.51) GRIK1GRIK2LMNAKMT2AMAOB
SCHEMBL5311091 0.76 PAM (0.68) HSD11B1GRIK1GRIK2LMNATP53
SCHEMBL5311088 0.76 PAM (0.68) HSD11B1GRIK1GRIK2LMNATP53
SCHEMBL21568848 0.75 NFE2L2 (0.50) HSD11B1LMNATP53POLBNFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814537-A2 MACROCYCLIC TERTIARY AMINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck & Co., Inc. (US) 2007-08-08 EP disclosed
WO-2006055434-A2 MACROCYCLIC TERTIARY AMINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2006-05-26 WO disclosed